3.43

17.15% -0.71

After Hours: 3.44 0.010 +0.29%

Protagenic Therapeutics Inc (PTIX)

Overview News Price History Financials Discussions Forecast Stock Split

Protagenic Therapeutics Inc stock is traded at $3.43, with a volume of 341.27K. It is down -17.15% in the last 24 hours and down -4.72% over the past month. Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Previous Close:

$4.14

Open:

24h Volume:

341.27K

Relative Volume:

0.13

Market Cap:

$6.57M

Revenue:

Net Income/Loss:

$-5.00M

P/E Ratio:

-2.9826

EPS:

-1.15

Net Cash Flow:

$-3.85M

1W Performance:

-21.15%

1M Performance:

-4.72%

6M Performance:

+25.58%

1Y Performance:

-60.95%

1-Day Range:

$3.28

$4.07

1-Week Range:

$3.28

$4.43

52-Week Range:

$2.25

$15.26

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Name

Protagenic Therapeutics Inc

Sector

Healthcare (1147)

Industry

Biotechnology (641)

Phone

(212) 994-8200

Address

149 FIFTH AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

PTIX's Discussions on Twitter

Compare PTIX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PTIX Protagenic Therapeutics Inc	3.43	7.93M	0	-5.00M	-3.85M	-1.15
VRTX Vertex Pharmaceuticals Inc	391.64	101.35B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	456.00	58.66B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	562.27	59.43B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	737.56	44.01B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	340.70	36.56B	3.81B	-644.79M	-669.77M	-6.24

Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Compare PTIX with other stocks

Protagenic Therapeutics Inc Stock (PTIX) Latest News

Measuring Protagenic Therapeutics Inc.’s beta against major indicesWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com

Will Protagenic Therapeutics Inc. (MBP0) stock outperform energy sector in 20252025 Market Overview & Trade Opportunity Analysis - newser.com

Applying Wyckoff theory to Protagenic Therapeutics Inc. Equity Warrant stockStop Loss & Weekly Sector Rotation Insights - newser.com

Can Protagenic Therapeutics Inc. Equity Warrant stock deliver sustainable ROEWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com

Is Protagenic Therapeutics Inc. stock a good choice for value investorsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com

Protagenic Therapeutics Inc Stock Analysis and ForecastDay Trading Setups & Minimal Risk High Reward - earlytimes.in

How moving averages guide Protagenic Therapeutics Inc. Equity Warrant tradingQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com

Using Bollinger Bands to evaluate Protagenic Therapeutics Inc.July 2025 Retail & Verified Short-Term Plans - newser.com

Will Protagenic Therapeutics Inc. stock outperform Dow Jones index2025 Risk Factors & Safe Capital Allocation Plans - newser.com

What the charts say about Protagenic Therapeutics Inc. Equity Warrant today2025 Fundamental Recap & Verified Short-Term Plans - newser.com

Why institutional investors increase stakes in Protagenic Therapeutics Inc. (MBP0) stockEarnings Growth Report & Consistent Profit Trading Strategies - newser.com

What drives Protagenic Therapeutics Inc stock priceInsider Trading Compliance & Budget Friendly Portfolio - earlytimes.in

Pattern recognition hints at Protagenic Therapeutics Inc. upsideJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com

Published on: 2025-09-30 00:57:35 - newser.com

Will Protagenic Therapeutics Inc. (MBP0) stock announce special dividend2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com

Does Protagenic Therapeutics Inc. Equity Warrant qualify in momentum factor screeningJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - newser.com

Will Protagenic Therapeutics Inc. Equity Warrant stock outperform tech sector in 2025Sell Signal & Technical Pattern Recognition Alerts - newser.com

Can Protagenic Therapeutics Inc. stock surprise with earnings upsideJuly 2025 Technicals & Verified Momentum Stock Watchlist - newser.com

Volatility clustering patterns for Protagenic Therapeutics Inc.2025 Analyst Calls & Weekly High Return Forecasts - newser.com

Chart based exit strategy for Protagenic Therapeutics Inc.Exit Point & Momentum Based Trading Ideas - newser.com

Tick level data insight on Protagenic Therapeutics Inc. Equity Warrant volatility2025 Market Outlook & Reliable Breakout Forecasts - newser.com

Published on: 2025-09-29 04:14:17 - newser.com

Why Protagenic Therapeutics Inc. Equity Warrant stock could be next big winnerJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com

Protagenic Therapeutics Inc Stock (PTIX) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to PTIX